AlphaSense

AI-Powered Market Intelligence

New York City, NY, USA

Other Research, Evidence & Knowledge Information & Knowledge ServicesGrowth

Enterprise search and data analytics company.

Shareable draft

Check out AlphaSense on @MedStartr Today Enterprise search and data analytics company. #LifeSciences #Healthcare #MentalBehavioralHealth #Other #ResearchEvidenceKnowledge #InformationKnowledgeServices #MedMo #MedStartrVentures

https://www.medstartr.ai/s/dRhjqB9OA-0

Get Involved in AlphaSense

How We Help

Problem Statement

Business and financial professionals face challenges making data-driven decisions due to the overwhelming volume and complexity of market information. AlphaSense solves this by providing a unified AI platform for efficient research, analysis, and extraction of critical insights.

Core Technology

AI platform leveraging artificial intelligence (AI), machine learning (ML), and natural language processing (NLP). Key features include Generative Search (with Deep Research), Smart Summaries, Generative Grid, and AI Workflow Agents.

Key Differentiators

Extensive and Proprietary Content Library (over 500 million documents daily), Purpose-Built AI for business and financial research, Advanced AI Features (Generative Search, Deep Research, Smart Summaries, Generative Grid), Unifies Quantitative and Qualitative Insights, Workflow Automation and Collaboration Tools, Enterprise-Grade Security and Scalability, and Strategic Acquisitions (e.g., Tegus, Sentieo, BamSEC, Canalyst).

Clinical Focus

The platform helps professionals in life sciences and healthcare sectors track evolving markets, disease areas, clinical trial pipelines, and regulatory changes. Its AI understands scientific nuances, including drug names and disease classifications, and provides access to critical healthcare sources like FDA, EMA, ClinicalTrials.gov, and PubMed.

Target Customers

Business and financial professionals, professionals in life sciences and healthcare sectors, large enterprise customers.

Product Stage

Mature

Company Info

Business Model: B2B, SaaS, Subscription-based
Founded: 2011
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.alpha-sense.com

Disease Areas

Life Sciences Healthcare Mental Health

Technologies

Machine LearningNLPGenerative AIAI & Machine Learning

🌐Website

MedStartr Engagement Score

Too Big!

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of AlphaSense?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.